Selected Publications:

W. Shan, C.J. Nicol, S. Ito, M.T. Bility, M.J. Kennett, J.M. Ward, F.J. Gonzalez and J.M. Peters (2008). Peroxisome proliferator-activated receptor-b/d protects against chemically-induced liver toxicity in mice. Hepatology 47: 225-235.

M.B. Crosby, J. Zhang, T.M. Nowling, J.L. Svenson, C.J. Nicol, F.J. Gonzalez and G.S. Gilkeson (2006). Inflammatory modulation of PPARg expression and activity. Clin. Immunol. 118: 276-283.

C.J. Nicol, M. Adachi, T.E. Akiyama and F.J. Gonzalez (2005). PPARg in endothelial cells influences high fat diet-induced hypertension. Am. J. Hypertens. 18: 549-556.

M.B. Crosby, J.L. Svenson, J. Zhang, C.J. Nicol, F.J. Gonzalez and G.S. Gilkeson (2005). Peroxisome proliferation-activated receptor (PPAR)g is not necessary for synthetic PPARg agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J. Pharmacol. Exp. Ther. 312: 69=76.

C.J. Nicol, M. Yoon, J.M. Ward, M. Yamashita, K. Fukamachi, J.M. Peters and F.J. Gonzalez (2004). PPARg influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis. Carcinogenesis 25: 1747-1755.

F.S. Harman*, C.J. Nicol*, H.E. Marin, J.M. Ward, F.J. Gonzalez and J.M. Peters (2004). Peroxisome proliferators-activated receptor-d attenuates colon carcinogenesis. Nat. Med. 10: 481-483. (*equally contributing co-first authors)

T.E. Akiyama*, G. Lambert*, C.J. Nicol*, K. Matsusue, J.M. Peters, H.B. Jr. Brewer and F.J. Gonzalez (2004). Peroxisome proliferators-activated receptor b/d regulates very low density lipoprotein production and catabolism in mice on a Western diet. J. Biol. Chem. 279: 20874-20881. (*equally contributing co-first authors)

C. Cheung, T.E. Akiyama, J.M. Ward, C.J. Nicol, L. Feigenbaum, C. Vinson and F.J. Gonzalez (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferators-activated receptor a. Cancer Res. 64: 3849-3854.

C.J. Nicol, J. Zielenski, L-C. Tsui and P.G. Wells (2000). An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J. 14: 111-127.

C.J. Nicol, M.L. Harrison, R.R. Laposa, I.L. Gimelshtein and P.G. Wells (1995). p53--A teratologic suppressor role for p53 in benzo[a]pyrene treated transgenic p53-deficient mice. Nat. Genet. 10: 181-187.